.med Domains Set for Big Release on September 30
On September 30, 2025, the internet registry operator Medistry LLC will open the gates on the highly anticipated .med Big Release. At 10:00 a.m. Eastern, thousands of premium medical-focused domain names will be available to the public for the first time. Registration will work on a first-come, first-served basis through accredited .med registrars.
Why This Release Matters
The .med extension is positioned squarely at the intersection of healthcare and digital identity. Having a short, memorable domain tied to medical expertise gives organizations and innovators a way to stand out in an online space where credibility is currency. Pharmacies, biotech firms, insurers, and clinics see this as an opportunity to claim digital real estate that signals trust immediately.
AI Leaders Fueling the Buzz
Interest is already pouring in from companies driving Artificial Intelligence in healthcare. Sophont.med is one of the most talked-about examples. The company builds multimodal foundation models—systems capable of processing text, imaging, and other types of clinical data together. Backed by Google Chief Scientist Jeff Dean, Google DeepMind’s Logan Kilpatrick, Delphi Ventures, Upfront Ventures, and Aiconic Ventures, Sophont is not exactly a quiet entrant. Their use of a .med address puts a spotlight on how this TLD is being embraced by innovators at the frontier of medicine and data science.
The Premium Names on Deck
Medistry’s Big Release includes an impressive catalog of names likely to draw intense competition. Examples include:
- Cardiology.med
- Oncology.med
- Sports.med
- Cloud.med
- Digital.med
- Radiology.med
- Sleep.med
- ER.med
These names cover everything from specialties to consumer-focused terms. Expect short, memorable names like Get.med and Link.med to move fast once the release goes live.
Corporations Already in Line
While AI startups have made headlines, established enterprises are not sitting out. CVS, Apple, Walmart, Kaiser, Novartis, Amgen, and Mayo Clinic Labs all secured their positions through Medistry’s pre-order system earlier this summer. For these companies, locking in a .med domain is part of a larger brand defense and trust-building strategy. They’re signaling to customers and patients that official communications and services can be found under a domain that immediately conveys authority.
Industry Reactions
Commentary from life sciences analysts reinforces the value. Pharmaphorum argued that credible medical sources using .med URLs can build confidence with consumers seeking reliable online information. AInvest put it bluntly: “The .med TLD is more than a domain—it’s a strategic asset for a world where digital health is no longer the future but the present.”
Looking Back: Lessons from .health and .pharmacy
This is not the first time the industry has seen health-focused domains introduced. When .pharmacy launched, the goal was to create a trusted online address for licensed pharmacies. While adoption was steady, growth was limited by strict eligibility rules that kept the namespace relatively small. It succeeded in signaling safety but lacked broad visibility.
The launch of .health was a different story. Expectations ran high, but the rollout drew criticism. Some medical groups questioned whether the extension could guarantee credibility if commercial interests dominated registrations. Adoption lagged, and the extension never gained the mainstream traction many had hoped for.
The .med release appears to have found a middle ground. With pre-orders already secured by major brands and strong interest from AI-driven startups, .med arrives with a mix of credibility and flexibility. Unlike .pharmacy, it is not restricted to a narrow set of license holders. Unlike .health, it launches in an era where digital health is no longer a niche conversation—it’s a core part of patient care and corporate strategy.
How Pricing Models Could Shift
The economics of this release are worth watching. Past launches created distinct patterns in pricing. .pharmacy was intentionally exclusive and carried higher costs, reflecting its limited eligibility. That kept adoption narrow but aligned with its mission of ensuring trust for licensed pharmacies only.
.health took a broader approach, with registrars offering prices similar to mainstream domains. The catch was that premium names—short words, specialties, or high-demand terms—were often locked behind auction models or higher “premium” tiers. This pushed costs into thousands of dollars per year for desirable names, leaving many smaller organizations on the sidelines.
.med could chart a different course. By offering premium inventory but also keeping general availability accessible, the registry may set pricing in a way that balances exclusivity with adoption. This hybrid strategy could echo what GoDaddy did in the retail registrar market—simplifying pricing tiers while still monetizing high-demand names. If that happens, registrants could see both competitive standard pricing for everyday use and premium rates reserved for headline names like Cardiology.med or Oncology.med.
The practical effect is that .med may become more broadly adopted than .pharmacy but hold greater prestige than .health. That pricing balance could be the factor that determines whether .med stays niche or becomes a default choice for medical brands and innovators worldwide.
How to Register
Participation is straightforward. Anyone interested can work with an accredited .med registrar or email Medistry directly at [email protected] for guidance. But speed will matter. Premium names often sell within minutes during releases of this kind, and there is no second chance once a competitor has locked in ownership.
The September 30 release is the most significant expansion for .med since its launch. With AI companies racing to showcase innovation and healthcare giants strengthening brand trust, the timing could not be sharper. History shows that past health-focused domains stumbled without early buy-in from both tech and traditional players. .med, by contrast, already has that buy-in. Its pricing approach may also prove decisive, offering both access and exclusivity. For organizations with any stake in health or science, the clock is ticking.